Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 167,466 | 169,411 | 157,991 | 159,194 | 127,722 |
| Cost of Goods | 50,678 | 50,627 | 36,074 | 39,007 | 34,651 |
| Gross Profit | 116,788 | 118,784 | 121,917 | 120,187 | 93,071 |
| Operating Expenses | 96,177 | 88,176 | 104,598 | 115,983 | 62,289 |
| Operating Income | 21,289 | 31,235 | 17,393 | 4,211 | 31,433 |
| Interest Expense | 9,856 | 8,833 | 10,246 | 10,423 | 7,333 |
| Other Income | -9,364 | -395 | 147 | 13 | 131 |
| Pre-tax Income | 2,069 | 22,007 | 7,294 | -6,199 | 24,231 |
| Income Tax | 2,762 | 2,131 | 466 | -1,069 | 6,571 |
| Net Income Continuous | -693 | 19,876 | 6,828 | -5,130 | 17,660 |
| Net Income | $-693 | $19,876 | $6,828 | $-5,130 | $17,660 |
| EPS Basic Total Ops | -0.02 | 0.44 | 0.15 | -0.12 | 0.40 |
| EPS Basic Continuous Ops | -0.02 | 0.44 | 0.15 | -0.12 | 0.40 |
| EPS Diluted Total Ops | -0.02 | 0.40 | 0.15 | -0.12 | 0.39 |
| EPS Diluted Continuous Ops | -0.02 | 0.38 | 0.15 | -0.11 | 0.39 |
| EBITDA(a) | $43,086 | $53,679 | $39,311 | $23,966 | $43,673 |